IRIS

Endosulfan

CASRN 115-29-7

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (15 pp, 122 K) last updated: 10/01/1994

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Urinary, Cardiovascular, Other 6 x 10-3 Reduced body weight gain in males and females increased incidence of marked progressive glomerulonephrosis and blood vessel aneurysms in males NOAEL : 6 x 10-1
mg/kg-day
100 Medium

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (15 pp, 122 K)
Not assessed under the IRIS Program.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (15 pp, 122 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (15 pp, 122 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (15 pp, 122 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.